These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

777 related items for PubMed ID: 965882

  • 21. Anti-implantation activity of antiestrogens and mifepristone.
    Dao B, Vanage G, Marshall A, Bardin CW, Koide SS.
    Contraception; 1996 Oct; 54(4):253-8. PubMed ID: 8922879
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Antigestagenic activity of Ixora finlaysoniana in rat.
    Singh MM, Chowdhury SR, Kulshreshtha DK, Kamboj VP.
    Contraception; 1993 Aug; 48(2):178-91. PubMed ID: 8403914
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR, Kletzky OA, Brenner PF, Roy S, Nicoloff J.
    Am J Obstet Gynecol; 1977 May 01; 128(1):60-74. PubMed ID: 403765
    [Abstract] [Full Text] [Related]

  • 28. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW, Chenault CB, de la Peña A, Dozier TS, Kraemer DC.
    Fertil Steril; 1978 Nov 01; 30(5):522-33. PubMed ID: 214353
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
    Scott JZ, Kletzky OA, Brenner PF, Mishell DR.
    Fertil Steril; 1978 Aug 01; 30(2):141-5. PubMed ID: 98356
    [Abstract] [Full Text] [Related]

  • 31. Development of a low-dose monthly injectable contraceptive system: I. Choice of compounds, dose and administration route.
    Garza-Flores J, Diaz-Sanchez V, Jimenez-Thomas S, Rudel HW.
    Contraception; 1984 Oct 01; 30(4):371-9. PubMed ID: 6509988
    [Abstract] [Full Text] [Related]

  • 32. A comparative study of the metabolic effects of injectable and oral contraceptives.
    Liew DF, Ng CS, Heng SH, Ratnam SS.
    Contraception; 1986 Apr 01; 33(4):385-94. PubMed ID: 2942334
    [Abstract] [Full Text] [Related]

  • 33. Effects of various progestational preparations on gonadotropin secretion in ovariectomized immature female rats.
    McPherson JC, Costoff A, Eldridge JC, Mahesh VB.
    Fertil Steril; 1974 Dec 01; 25(12):1063-70. PubMed ID: 4430386
    [Abstract] [Full Text] [Related]

  • 34. Action of luteinizing hormone-releasing factor (lrf) in the initiation of lordosis behavior in the estrone-primed ovariectomized female rat.
    Moss RL, McCann SM.
    Neuroendocrinology; 1975 Dec 01; 17(4):309-18. PubMed ID: 806824
    [Abstract] [Full Text] [Related]

  • 35. Endocrinological and physiological features after steroid treatment of male rats.
    Hunt DM, Lau IF, Saksena SK, Chang MC.
    Arch Androl; 1978 Sep 01; 1(4):311-20. PubMed ID: 736678
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetic study of different doses of Depo Provera.
    Fotherby K, Koetsawang S, Mathrubutham M.
    Contraception; 1980 Nov 01; 22(5):527-36. PubMed ID: 6451351
    [Abstract] [Full Text] [Related]

  • 37. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
    Knuth UA, Yeung CH, Nieschlag E.
    Fertil Steril; 1989 Jun 01; 51(6):1011-8. PubMed ID: 2524404
    [Abstract] [Full Text] [Related]

  • 38. The effect of prostaglandins and other vasoactive substances on uterine blood flow and myometrial activity.
    Still JG, Greiss FC.
    Am J Obstet Gynecol; 1978 Jan 01; 130(1):1-8. PubMed ID: 619633
    [Abstract] [Full Text] [Related]

  • 39. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin.
    Swahn ML, Bygdeman M.
    Br J Obstet Gynaecol; 1988 Feb 01; 95(2):126-34. PubMed ID: 3349002
    [Abstract] [Full Text] [Related]

  • 40. Levels of contraceptive seroids in breast milk and plasma of lactating women.
    Saxena BN, Shrimanker K, Grudzinskas JG.
    Contraception; 1977 Dec 01; 16(6):605-13. PubMed ID: 606500
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.